Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

MDUFA Negotiations Mellow Out Over Opposing Wish Lists

This article was originally published in The Gray Sheet

Executive Summary

As FDA and industry struggle to align on reform priorities for a cost-conscious user-fee reauthorization proposal, the two sides took a step back to examine basic assumptions at a recent closed-door meeting.


Related Content

Shuren: FDA Willing to Kick-Start Device Evaluation Program, But Funding Guarantee Needed
New Fundings And Goals To Match Raised In Latest MDUFA IV Session